Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(63%)
Results Posted
33%(1 trials)

Phase Distribution

Ph early_phase_1
6
75%
Ph phase_1
2
25%

Phase Distribution

8

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
6(75.0%)
Phase 1Safety & dosage
2(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(3)

Detailed Status

Active, not recruiting4
Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 16 (75.0%)
Phase 12 (25.0%)

Trials by Status

completed338%
active_not_recruiting450%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8